Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with RGNX: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
RGNX
Regenxbio Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
RGNX
Regenxbio Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
478.34
▲
+3.70%
· post 480.00
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
RGNX
Regenxbio Inc.
Change
7.72
▲
+1.17%
· post 7.72
Closed
Nov 4 '26
Mkt cap
$503.7M
Revenue
$108M
Q2 FY26
Revenue
$170M
FY25
vs
Compare
Closed
Nov 4 '26
AMGN
Amgen Inc
vs
RGNX
Regenxbio Inc.
478.34
▲
+3.70%
post 480.00
Price
7.72
▲
+1.17%
post 7.72
$258.8B
Mkt cap
$503.7M
Q3 FY26
$10.4B
Revenue
$108M
Q2 FY26
FY25
$36.8B
Revenue
$170M
FY25
Change
Change
AMGN
478.34
▲
+3.70%
vs
RGNX
7.72
▲
+1.17%
Closed
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RGNX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only RGNX
17
ABBV
AbbVie Global Enterprises Ltd. (AbbVie)
customer
RARE
Ultragenyx Pharmaceutical
customer
GSK
GlaxoSmithKline LLC (GSK)
supplier
NVS
Novartis Gene Therapies, Inc. (formerly AveXis, Inc.) (Novartis Gene Therapies)
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
customer
13 more · RGNX chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
RGNX, dashed